ABHRS Holds Exam in Capri, Italy

July 2010 in “ Hair transplant forum international ”

Robert H. True

TLDR The ABHRS held a test in Capri, Italy.

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on ishrs-htforum.org →

Discuss this study in the Community →

Semantic ratio: 80%

Related Community Posts Join

6 / 1000+ results

community ABS-201 KOL Seminar: Dr. Ralf Paus on Human Ex Vivo Hair Regrowth Data

in Research/Science 15 upvotes 3 months ago

ABS-201 shows promise for male hair regrowth by blocking the prolactin receptor, with higher expected efficacy than current treatments. The discussion also covers dosing differences between macaques and humans for hmi115, highlighting a significant dosage disparity.

community After Finasteride now it's the turn to get Dutasteride easily in Italy!

in Finasteride/Dutasteride 91 upvotes 1 year ago

An individual in Italy used a fake prescription to obtain Dutasteride cheaply, suggesting others do the same to avoid high costs. They discuss the effectiveness and side effects of Dutasteride compared to Finasteride for hair loss, with some users considering switching due to better tolerance.

community 25M from Italy – Need Advice on Getting Finasteride

in General 61 upvotes 10 months ago

A 25-year-old from Italy is experiencing hair thinning and seeks advice on obtaining finasteride, which requires a prescription in Italy. Suggestions include consulting a local doctor or using telehealth services.

community Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!

in Research/Science 3 upvotes 7 months ago

A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.

community Allergan recruiting for Setipiprant trial in the US

13 upvotes 8 years ago

The conversation discusses a clinical trial for Setipiprant in the US, starting June 29th, with eligibility excluding recent users of minoxidil or finasteride. It encourages informed decision-making before signing up.